March 2014

Rheonix Invited to Present at ‘The Future of In-Vitro Diagnostics’ Conference hosted by Siemens

ITHACA, N.Y. – March 24, 2014 - Rheonix, Inc., a developer of fully automated molecular testing solutions, announced today that it has been invited to exhibit at “The Future of In-Vitro Diagnostics.” The exclusive conference, held April 10, 2014 in Menlo Park/Palo Alto, CA, is hosted by Siemens Venture Capital, the investment arm of Siemens, and Siemens Healthcare. The fifth annual conference brings together over 100 CEOs and CTOs, investors, key… Read More »

Rheonix Further Expands Intellectual Property Portfolio with Six Patents for Its Microfluidic Systems

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted six additional patents for its core microfluidic device, the Chemistry and Reagent Device, or CARD® . One patent was issued Feb. 11, while the other five have been allowed but not yet issued. The Rheonix CARD is a disposable cartridge the size of a credit card that runs multiple samples simultaneously without user intervention. Once… Read More »